Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models?
The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Abstract
While it has long been thought that most of cerebral creatine is of peripheral origin, the last 20 years has provided evidence that the creatine synthetic pathway (AGAT and GAMT enzymes) is expressed in the brain together with the creatine transporter (SLC6A8). It has also been shown that SLC6A8 is expressed by microcapillary endothelial cells at the blood-brain barrier, but is absent from surrounding astrocytes, raising the concept that the blood-brain barrier has a limited permeability for peripheral creatine. The first creatine deficiency syndrome in humans was also discovered 20 years ago (GAMT deficiency), followed later by AGAT and SLC6A8 deficiencies, all three diseases being characterized by creatine deficiency in the CNS and essentially affecting the brain. By reviewing the numerous and latest experimental studies addressing creatine transport and synthesis in the CNS, as well as the clinical and biochemical characteristics of creatine-deficient patients, our aim was to delineate a clearer view of the roles of the blood-brain and blood-cerebrospinal fluid barriers in the transport of creatine and guanidinoacetate between periphery and CNS, and on the intracerebral synthesis and transport of creatine. This review also addresses the question of guanidinoacetate toxicity for brain cells, as probably found under GAMT deficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some individuals have been found to have creatine synthesis deficiencies due to inborn errors in AGAT, GMAT and/or creatine transporter (CRTR) deficiencies and therefore must depend on dietary creatine intake in order to maintain normal muscle and brain concentrations of PCr and Cr”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [19]
In the citing paper
“clinical populations may need to consume 10–30 g/day throughout their lifespan to offset creatine synthesis deficiencies and/or provide therapeutic benefit in various disease states”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [19]
In the citing paper
“However, higher levels of creatine supplementation for longer periods of time may be needed to increase brain concentrations of creatine, offset creatine synthesis deficiencies, or influence disease states”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [19]
In the citing paper
“Dietary supplementation of 20–30 g/day of creatine monohydrate for up to 5 years has also been studied in some clinical populations who need higher levels to increase brain concentrations of creatine, offset creatine synthesis deficiencies, or influence disease states [51,52,53].”
From Creatine in health and disease (2021) · cites this paper as [52]
In the citing paper
“some of the dietary creatine and creatine synthesized in the liver enters the brain via the SLC6A8 Cr transporter (CT1), which is expressed in the microcapillaries of the BBB, neurons, and oligodendrocytes [241]”
From Creatine monohydrate supplementation for older adults and clinical populations (2025) · cites this paper as [241]
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950 · cited 9×
“Brain Cr was long thought to essentially come from the periphery (Wyss and Kaddurah-Daouk 2000).”
InfluentialWallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., & Eppenberger, H. M. (1992) · Biochemical Journal · doi:10.1042/bj2810021 · Cited by 2,011
The creatine kinase system and pleiotropic effects of creatine
Wallimann, T., Tokarska-Schlattner, M., & Schlattner, U. (2011) · Amino Acids · doi:10.1007/s00726-011-0877-3 · Cited by 797
Mitochondrial creatine kinase in human health and disease
Schlattner, U., Tokarska-Schlattner, M., & Wallimann, T. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.09.004 · Cited by 622
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417 · cited 5×
“…with high Cr doses slowly replenishes their brain Cr pool, demonstrating that it can nevertheless be taken up from the periphery into the CNS through the SLC6A8 transporter expressed on MCEC at the BBB (Stöckler et al. 1994; Schulze et al. 1997; Braissant 2014; Stöckler-Ipsiroglu et al. 2014).”
InfluentialChen, N.-H., Reith, M. E. A., & Quick, M. W. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1064-5 · Cited by 409
X-Linked Creatine-Transporter Gene (SLC6A8) Defect: A New Creatine-Deficiency Syndrome
Salomons, G. S., van Dooren, S. J. M., Verhoeven, N. M., Cecil, K. M., Ball, W. S., Degrauw, T. J., & Jakobs, C. (2001) · The American Journal of Human Genetics · doi:10.1086/320595 · Cited by 396
Creatine kinase in non-muscle tissues and cells
Wallimann, T., & Hemmer, W. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf01267955 · Cited by 374
Creatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement
Brosnan, J. T., & Brosnan, M. E. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093621 · Cited by 347
Braissant, O., McLin, V. A., & Cudalbu, C. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9546-2 · Cited by 287
Self-citationThe metabolic burden of creatine synthesis
Brosnan, J. T., da Silva, R. P., & Brosnan, M. E. (2011) · Amino Acids · doi:10.1007/s00726-011-0853-y · Cited by 284
Stöckler, S., Hanefeld, F., & Frahm, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04116-5 · Cited by 240
Item, C. B., Stöckler-Ipsiroglu, S., Stromberger, C., Mühl, A., Alessandrì, M. G., Bianchi, M. C., Tosetti, M., Fornai, F., & Cioni, G. (2001) · The American Journal of Human Genetics · doi:10.1086/323765 · Cited by 233
Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study
Braissant, O., Henry, H., Loup, M., Eilers, B., & Bachmann, C. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00269-2 · Cited by 232
Self-citationWallimann, T., Dolder, M., Schlattner, U., Eder, M., Hornemann, T., O'Gorman, E., Rück, A., & Brdiczka, D. (1998) · BioFactors · doi:10.1002/biof.5520080310 · Cited by 230 · cited 1×
“…GAMT guanidinoacetate methyltransferase, Gly glycine, Orn ornithine, SAH S-adenosyl homocysteine, SAM S-adenosyl methionine, SLC6A8 Cr transporter 1 3 CKs control energy demand through PCr consumption for local ATP production at subcellular sites of high energy demand (Wallimann et al. 1992, 1998).”
Sestili, P., Martinelli, C., Bravi, G., Piccoli, G., Curci, R., Battistelli, M., Falcieri, E., Agostini, D., Gioacchini, A. M., & Stocchi, V. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.035 · Cited by 220 · cited 1×
“Additionally, Cr was shown to reduce the cytotoxic effect in several oxidatively-injured human and murine cultured cell lines without affecting antioxidant enzyme activities, hinting at a direct scavenging of ROS and NOS by Cr (Sestili et al. 2006).”
Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man.
Stöckler, S., Isbrandt, D., Hanefeld, F. A., Schmidt, B., & FIGURA, K. V. (1996) · PubMed · Cited by 219
High Prevalence of SLC6A8 Deficiency in X-Linked Mental Retardation
Rosenberg, E. H., Almeida, L. S., Kleefstra, T., deGrauw, R. S., Yntema, H. G., Bahi, N., Moraine, C., Ropers, H.-H., Fryns, J.-P., deGrauw, T. J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/422102 · Cited by 213
The role of creatine kinase in inhibition of mitochondrial permeability transition
(1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01045-4 · Cited by 210
Ohtsuki, S., Tachikawa, M., Takanaga, H., Shimizu, H., Watanabe, M., Hosoya, K.-I., & Terasaki, T. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200211000-00006 · Cited by 196
Inhibition of the Mitochondrial Permeability Transition by Creatine Kinase Substrates
Dolder, M., Walzel, B., Speer, O., Schlattner, U., & Wallimann, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208705200 · Cited by 194
Synthesis and transport of creatine in the CNS: Importance for cerebral functions
Béard, E., & Braissant, O. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06935.x · Cited by 192
Self-citationNeuroprotective effects of creatine
Beal, M. F. (2011) · Amino Acids · doi:10.1007/s00726-011-0851-0 · Cited by 188
Cecil, K. M., Salomons, G. S., Ball, W. S., Wong, B., Chuck, G., Verhoeven, N. M., Jakobs, C., & DeGrauw, T. J. (2001) · Annals of Neurology · doi:10.1002/ana.79 · Cited by 181
Tachikawa, M., Fukaya, M., Terasaki, T., Ohtsuki, S., & Watanabe, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03478.x · Cited by 173
Schmidt, A. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh112 · Cited by 171
Schulze, A., Hess, T., Wevers, R., Mayatepek, E., Bachert, P., Marescau, B., Knopp, M. V., De Deyn, P. P., Bremer, H. J., & Rating, D. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70075-1 · Cited by 170
Schulze, A., Ebinger, F., Rating, D., & Mayatepek, E. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3257 · Cited by 161
da Silva, R. P., Nissim, I., Brosnan, M. E., & Brosnan, J. T. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90547.2008 · Cited by 160
GAMT deficiency: Features, treatment, and outcome in an inborn error of creatine synthesis
Mercimek-Mahmutoglu, S., Stoeckler-Ipsiroglu, S., Adami, A., Appleton, R., Araújo, H. C., Duran, M., Ensenauer, R., Fernandez-Alvarez, E., Garcia, P., Grolik, C., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000234852.43688.bf · Cited by 158
Brady, S. T., & Lasek, R. J. (1981) · Cell · doi:10.1016/0092-8674(81)90147-1 · Cited by 157
Reversible brain creatine deficiency in two sisters with normal blood creatine level
Bianchi, M. C., Tosetti, M., Fornai, F., Grazia Alessandri', M., Cipriani, P., De Vito, G., & Canapicchi, R. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<511::aid-ana15>3.0.co;2-n · Cited by 148
Creatine deficiency syndromes and the importance of creatine synthesis in the brain
Braissant, O., Henry, H., Béard, E., & Uldry, J. (2011) · Amino Acids · doi:10.1007/s00726-011-0852-z · Cited by 145
Self-citationStockler-Ipsiroglu, S., van Karnebeek, C., Longo, N., Korenke, G. C., Mercimek-Mahmutoglu, S., Marquart, I., Barshop, B., Grolik, C., Schlune, A., Angle, B., et al. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.10.018 · Cited by 145
Clark, A. J., Rosenberg, E. H., Almeida, L. S., Wood, T. C., Jakobs, C., Stevenson, R. E., Schwartz, C. E., & Salomons, G. S. (2006) · Human Genetics · doi:10.1007/s00439-006-0162-9 · Cited by 144
Choe, C.-U., Atzler, D., Wild, P. S., Carter, A. M., Böger, R. H., Ojeda, F., Simova, O., Stockebrand, M., Lackner, K., Nabuurs, C., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000580 · Cited by 143
Brosnan, J. T., Wijekoon, E. P., Warford‐Woolgar, L., Trottier, N. L., Brosnan, M. E., Brunton, J. A., & Bertolo, R. F. P. (2009) · Journal of Nutrition · doi:10.3945/jn.109.105411 · Cited by 137
Creatine Metabolism in Skeletal Muscle
Fitch, C. D., Shields, R. P., Payne, W. F., & Dacus, J. M. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93544-1 · Cited by 134
Exocytotic release of creatine in rat brain
Almeida, L. S., Salomons, G. S., Hogenboom, F., Jakobs, C., & Schoffelmeer, A. N. M. (2006) · Synapse · doi:10.1002/syn.20280 · Cited by 130
Activation of GABAA Receptors by Guanidinoacetate: A Novel Pathophysiological Mechanism
Neu, A., Neuhoff, H., Trube, G., Fehr, S., Ullrich, K., Roeper, J., & Isbrandt, D. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0547 · Cited by 127
Braissant, O., Henry, H., Villard, A.-M., Speer, O., Wallimann, T., & Bachmann, C. (2005) · BMC Developmental Biology · doi:10.1186/1471-213x-5-9 · Cited by 125
Self-citationCreatine Transporter (CrT; Slc6a8) Knockout Mice as a Model of Human CrT Deficiency
Skelton, M. R., Schaefer, T. L., Graham, D. L., deGrauw, T. J., Clark, J. F., Williams, M. T., & Vorhees, C. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016187 · Cited by 124
Ceddia, R. B., & Sweeney, G. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.056291 · Cited by 121
Braissant, O., & Henry, H. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0826-9 · Cited by 116
Self-citationCreatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers
Braissant, O. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9433-2 · Cited by 112 · cited 10×
“This probably illustrates the greater permeability of the BBB for Cr at early postnatal stages during which Cr exerts essential roles in CNS development (Braissant et al. 2005; Braissant 2012).”
Self-citationPresymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency
Schulze, A., Hoffmann, G. F., Bachert, P., Kirsch, S., Salomons, G. S., Verhoeven, N. M., & Mayatepek, E. (2006) · Neurology · doi:10.1212/01.wnl.0000230152.25203.01 · Cited by 110
Role of AMP‐Activated Protein Kinase in the Control of Appetite
Kola, B. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01745.x · Cited by 110
Guanidinoacetate methyltransferase deficiency: New clinical features
Ganesan, V., Johnson, A., Connelly, A., Eckhardt, S., & Surtees, R. A. H. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00083-0 · Cited by 108
Schloss, P. D., Mayser, W., & Betz, H. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1093 · Cited by 107
Guthmiller, P., Van Pilsum, J. F., Boen, J. R., & McGuire, D. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32477-8 · Cited by 106
Ammonium-Induced Impairment of Axonal Growth Is Prevented through Glial Creatine
Braissant, O., Henry, H., Villard, A.-M., Zurich, M.-G., Loup, M., Eilers, B., Parlascino, G., Matter, E., Boulat, O., Honegger, P., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09810.2002 · Cited by 106
Self-citationCongenital Creatine Transporter Deficiency
deGrauw, T. J., Salomons, G. S., Cecil, K. M., Chuck, G., Newmeyer, A., Schapiro, M. B., & Jakobs, C. (2002) · Neuropediatrics · doi:10.1055/s-2002-36743 · Cited by 106
Battini, R., Leuzzi, V., Carducci, C., Tosetti, M., Bianchi, M. C., Item, C. B., Stöckler‐Ipsiroglu, S., & Cioni, G. (2002) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00175-0 · Cited by 105
High frequency of creatine deficiency syndromes in patients with unexplained mental retardation
Lion‐François, L., Cheillan, D., Pitelet, G., Acquaviva, C., Bussy, G., Cotton, F., Guibaud, L., Gérard, D., Rivier, C., Vianey‐Saban, C., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000239153.39710.81 · Cited by 101
Battini, R., Alessandrì, M. G., Leuzzi, V., Moro, F., Tosetti, M., Bianchi, M. C., & Cioni, G. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.01.043 · Cited by 101 · cited 2×
“As for GAMT deficiency, the early pre-symptomatic treatment of AGAT-deficient patients with oral Cr appears to protect their CNS development, suggesting a better crossing of Cr through the BBB in fetal and postnatal life (Battini et al. 2006; Schulze and Battini 2007).”
‘Hot spots’ of creatine kinase localization in brain: cerebellum, hippocampus and choroid plexus
Kaldis, P., Hemmer, W., Zanolla, E., Holtzman, D., & Wallimann, T. (2009) · Developmental Neuroscience · doi:10.1159/000111452 · Cited by 99 · cited 1×
“It suggests that these neuronal layers permanently need high Cr levels, in line with their high creatine kinase activity (Wallimann and Hemmer 1994; Kaldis et al. 1996; Braissant et al. 2010).”
Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency
Kurosawa, Y., DeGrauw, T. J., Lindquist, D. M., Blanco, V. M., Pyne-Geithman, G. J., Daikoku, T., Chambers, J. B., Benoit, S. C., & Clark, J. F. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59373 · Cited by 98
l-arginine:glycine amidinotransferase deficiency protects from metabolic syndrome
Choe, C.-U., Nabuurs, C., Stockebrand, M. C., Neu, A., Nunes, P., Morellini, F., Sauter, K., Schillemeit, S., Hermans-Borgmeyer, I., Marescau, B., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds407 · Cited by 97
Nabuurs, C. I., Choe, C. U., Veltien, A., Kan, H. E., van Loon, L. J. C., Rodenburg, R. J. T., Matschke, J., Wieringa, B., Kemp, G. J., Isbrandt, D., et al. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.241760 · Cited by 95
Dissociation of AGAT, GAMT and SLC6A8 in CNS: Relevance to creatine deficiency syndromes
Braissant, O., Béard, E., Torrent, C., & Henry, H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.022 · Cited by 94 · cited 22×
“This review brings together (a) both in vitro and in vivo experimental data on Cr synthesis and transport in the brain with (b) the CNS biochemical characteristics observed in patients deficient for AGAT, GAMT and SLC6A8 as well as in the respective rodent models for Cr deficiencies, to delineate a clearer view of the…”
Self-citationCreatine Transport in Cultured Cells of Rat and Mouse Brain
Möller, A., & Hamprecht, B. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09154.x · Cited by 90
Staufner, C., & Peters, V. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9734-3 · Cited by 88
X‐linked creatine deficiency syndrome: A novel mutation in creatine transporter gene SLC6A8
Bizzi, A., Bugiani, M., Salomons, G. S., Hunneman, D. H., Moroni, I., Estienne, M., Danesi, U., Jakobs, C., & Uziel, G. (2002) · Annals of Neurology · doi:10.1002/ana.10246 · Cited by 88
Clinical features and X-inactivation in females heterozygous for creatine transporter defect
van de Kamp, J., Mancini, G., Pouwels, P., Betsalel, O., van Dooren, S., de Koning, I., Steenweg, M., Jakobs, C., van der Knaap, M., & Salomons, G. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01460.x · Cited by 88
Ireland, Z., Dickinson, H., Snow, R. J., & Walker, D. W. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.10.790 · Cited by 87
Gatm, a creatine synthesis enzyme, is imprinted in mouse placenta
Sandell, L. L., Guan, X.-J., Ingram, R., & Tilghman, S. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230424100 · Cited by 82
Fink, G. R., Driver, J., Rorden, C., Baldeweg, T., & Dolan, R. J. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<440::aid-ana6>3.0.co;2-e · Cited by 82
Wallimann, T., Tokarska‐Schlattner, M., Neumann, D., Epand, R. M., Epand, R. F., Andres, R. H., Widmer, H. R., Hornemann, T., Saks, V., Agarkova, I., et al. (2007) · Molecular System Bioenergetics · doi:10.1002/9783527621095.ch7 · Cited by 80
Kinetics of creatine in blood and brain after intraperitoneal injection in the rat
Perasso, L., Cupello, A., Lunardi, G. L., Principato, M. C., Gandolfo, C., & Balestrino, M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02547-2 · Cited by 76
Arias, Á., Corbella, M., Fons, C., Sempere, Á., García‐Villoria, J., Ormazábal, A., Póo, P., Pineda, M., Vilaseca, M. A., Campistol, J., et al. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.07.010 · Cited by 75
X‐Linked creatine transporter deficiency in two patients with severe mental retardation and autism
Póo‐Argüelles, P., Arias, A., Vilaseca, M. A., Ribes, A., Artuch, R., Sans‐Fito, A., Moreno, A., Jakobs, C., & Salomons, G. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0212-4 · Cited by 74
Bothwell, J. H., Rae, C., Dixon, R. M., Styles, P., & Bhakoo, K. K. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00403.x · Cited by 72
Cerebral Creatine Deficiencies: A Group of Treatable Intellectual Developmental Disorders
van Karnebeek, C., & Stockler-Ipsiroglu, S. (2014) · Seminars in Neurology · doi:10.1055/s-0034-1386772 · Cited by 72
Ensenauer, R., Thiel, T., Schwab, K. O., Tacke, U., Stöckler-Ipsiroglu, S., Schulze, A., Hennig, J., & Lehnert, W. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.04.005 · Cited by 71 · cited 1×
“This mechanism has, however, never been shown in humans even though PGAA accumulation is known to occur in muscles of GAMT-deficient patients (Ensenauer et al. 2004).”
Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress
Alfieri, R. R., Bonelli, M. A., Cavazzoni, A., Brigotti, M., Fumarola, C., Sestili, P., Mozzoni, P., De Palma, G., Mutti, A., Carnicelli, D., et al. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.115006 · Cited by 70
Immunohistochemical localisation of the creatine transporter in the rat brain
Mak, C., Waldvogel, H. J., Dodd, J. R., Gilbert, R. T., Lowe, M. T. J., Birch, N. P., Faull, R. L. M., & Christie, D. L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.065 · Cited by 70
Brain creatine functions to attenuate acute stress responses through GABAnergic system in chicks
Koga, Y., Takahashi, H., Oikawa, D., Tachibana, T., Denbow, D. M., & Furuse, M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.004 · Cited by 70
Stockler-Ipsiroglu, S., Apatean, D., Battini, R., DeBrosse, S., Dessoffy, K., Edvardson, S., Eichler, F., Johnston, K., Koeller, D. M., Nouioua, S., et al. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.10.003 · Cited by 69
Valayannopoulos, V., Boddaert, N., Chabli, A., Barbier, V., Desguerre, I., Philippe, A., Afenjar, A., Mazzuca, M., Cheillan, D., Munnich, A., et al. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9358-9 · Cited by 69
Pre-Symptomatic Treatment of Creatine Biosynthesis Defects
Schulze, A., & Battini, R. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-6486-9_9 · Cited by 68
Zugno, A. I., Stefanello, F. M., Scherer, E. B. S., Mattos, C., Pederzolli, C. D., de Andrade, V. M., Wannmacher, C. M. D., Wajner, M., Dutra‐Filho, C. S., & Wyse, Â. T. D. S. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9636-6 · Cited by 66
Lensman, M. V., Korzhevsky, D. E., Mourovets, V. O., Kostkin, V. B., Izvarina, N. L., Perasso, L., Gandolfo, C., Otellin, V. A., Polenov, S. A., & Balestrino, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.103 · Cited by 65
PIKfyve in the SGK1 Mediated Regulation of the Creatine Transporter SLC6A8
Strutz-Seebohm, N., Shojaiefard, M., Christie, D., Tavare, J., Seebohm, G., & Lang, F. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110433 · Cited by 64
Stimulation of the creatine transporter SLC6A8 by the protein kinases SGK1 and SGK3
Shojaeifard, M. B., Christie, D. L., & Lang, F. J. W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.164 · Cited by 64
Ireland, Z., Russell, A. P., Wallimann, T., Walker, D. W., & Snow, R. (2009) · BMC Developmental Biology · doi:10.1186/1471-213x-9-39 · Cited by 63
Tachikawa, M., Fujinawa, J., Takahashi, M., Kasai, Y., Fukaya, M., Sakai, K., Yamazaki, M., Tomi, M., Watanabe, M., Sakimura, K., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05652.x · Cited by 59
Renema, W. K. J., Schmidt, A., van Asten, J. J. A., Oerlemans, F., Ullrich, K., Wieringa, B., Isbrandt, D., & Heerschap, A. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10627 · Cited by 59
Abplanalp, J., Laczko, E., Philp, N. J., Neidhardt, J., Zuercher, J., Braun, P., Schorderet, D. F., Munier, F. L., Verrey, F., Berger, W., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt175 · Cited by 59
Zugno, A. I., Scherer, E. B. S., Schuck, P. F., de Oliveira, D. L., Wofchuk, S., Wannmacher, C. M. D., Wajner, M., & Wyse, Â. T. D. S. (2006) · Metabolic Brain Disease · doi:10.1007/s11011-006-9003-8 · Cited by 57
Deyn, P. P. D., Marescau, B., & Macdonald, R. L. (1991) · Epilepsy Research · doi:10.1016/0920-1211(91)90081-p · Cited by 57
Braissant, O., Cagnon, L., Monnet‐Tschudi, F., Speer, O., Wallimann, T., Honegger, P., & Henry, H. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06126.x · Cited by 57
Self-citationLowe, M. T. J., Faull, R. L. M., Christie, D. L., & Waldvogel, H. J. (2015) · Journal of Comparative Neurology · doi:10.1002/cne.23667 · Cited by 54
Arginine supplementation in four patients with X‐linked creatine transporter defect
Fons, C., Sempere, A., Arias, A., López‐Sala, A., Póo, P., Pineda, M., Mas, A., Vilaseca, M. A., Salomons, G. S., Ribes, A., et al. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0902-1 · Cited by 53
A novel mouse model of creatine transporter deficiency
Baroncelli, L., Alessandri, M., Tola, J., Putignano, E., Migliore, M., Amendola, E., Zonfrillo, F., Gross, C., Leuzzi, V., Cioni, G., et al. (2014) · F1000Research · doi:10.12688/f1000research.5369.1 · Cited by 52
New insights into creatine function and synthesis
Brosnan, M. E., Edison, E. E., da Silva, R. P., & Brosnan, J. T. (2007) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.12.005 · Cited by 51
Tachikawa, M., Kasai, Y., Yokoyama, R., Fujinawa, J., Ganapathy, V., Terasaki, T., & Hosoya, K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06332.x · Cited by 49
Chilosi, A., Leuzzi, V., Battini, R., Tosetti, M., Ferretti, G., Comparini, A., Casarano, M., Moretti, E., Alessandrì, M. G., Bianchi, M. C., et al. (2008) · Neurocase · doi:10.1080/13554790802060821 · Cited by 49
Stimulation of the creatine transporter SLC6A8 by the protein kinase mTOR
Shojaeifard, M. B., Christie, D. L., & Lang, F. J. W. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.055 · Cited by 48
Mercimek-Mahmutoglu, S., Ndika, J., Kanhai, W., de Villemeur, T. B., Cheillan, D., Christensen, E., Dorison, N., Hannig, V., Hendriks, Y., Hofstede, F. C., et al. (2014) · Human Mutation · doi:10.1002/humu.22511 · Cited by 47
Cunha, M. P., Martín-de-Saavedra, M. D., Romero, A., Egea, J., Ludka, F. K., Tasca, C. I., Farina, M., Rodrigues, A. L. S., & López, M. G. (2014) · ASN Neuro · doi:10.1177/1759091414554945 · Cited by 44
Hanna-El-Daher, L., Béard, E., Henry, H., Tenenbaum, L., & Braissant, O. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.029 · Cited by 43
Self-citationLee, H., Ogawa, H., Fujioka, M., & Gerton, G. L. (1994) · Biology of Reproduction · doi:10.1095/biolreprod50.1.152 · Cited by 42
Biochemical and behavioural phenotyping of a mouse model for GAMT deficiency
Torremans, A., Marescau, B., Possemiers, I., Dam, D. V., D’Hooge, R., Isbrandt, D., & Deyn, P. P. D. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.12.014 · Cited by 41
Na+/Cl−/creatine transporter activity and expression in rat brain synaptosomes
Peral, M. J., Vázquez-Carretero, M. D., & Ilundain, A. A. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.001 · Cited by 40
Possible role of creatine concentrations in the brain in regulating appetite and weight
Galbraith, R. A., Furukawa, M., & Li, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.032 · Cited by 37
Trotier-Faurion, A., Dézard, S., Taran, F., Valayannopoulos, V., de Lonlay, P., & Mabondzo, A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400545n · Cited by 36 · cited 1×
“…or transported by lipid nanocapsules) which would allow the crossing of plasma membrane independently of SLC6A8 while achieving Cr roles within CNS. (Perasso et al. 2008, 2009; Adriano et al. 2011; Burov et al. 2011; Vlasov et al. 2011; Kurosawa et al. 2012; Trotier-Faurion et al. 2013, 2015).”
New insights into creatine transporter deficiency: the importance of recycling creatine in the brain
van de Kamp, J. M., Jakobs, C., Gibson, K. M., & Salomons, G. S. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9537-3 · Cited by 35
AMPK and substrate availability regulate creatine transport in cultured cardiomyocytes
Darrabie, M. D., Arciniegas, A. J. L., Mishra, R., Bowles, D. E., Jacobs, D. O., & Santacruz, L. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00554.2010 · Cited by 35
1H MR spectroscopy of the brain in Cr transporter defect
Sijens, P. E., Verbruggen, K. T., Oudkerk, M., Spronsen, V. F., & Soorani‐Lunsing, R. J. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.08.004 · Cited by 34
In vivo neuroprotection by a creatine-derived compound: Phosphocreatine–Mg-complex acetate
Perasso, L., Adriano, E., Ruggeri, P., Burov, S. V., Gandolfo, C., & Balestrino, M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.009 · Cited by 31
Bothwell, J. H., Styles, P., & Bhakoo, K. K. (2002) · Journal of Membrane Biology · doi:10.1007/s00232-001-0121-2 · Cited by 31
Trotier-Faurion, A., Passirani, C., Béjaud, J., Dézard, S., Valayannopoulos, V., Taran, F., de Lonlay, P., Benoit, J.-P., & Mabondzo, A. (2015) · Nanomedicine · doi:10.2217/nnm.13.205 · Cited by 31
Protective Effects of Some Creatine Derivatives in Brain Tissue Anoxia
Perasso, L., Lunardi, G. L., Risso, F., Pohvozcheva, A. V., Leko, M. V., Gandolfo, C., Florio, T., Cupello, A., Burov, S. V., & Balestrino, M. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9492-9 · Cited by 29
Female mice heterozygous for creatine transporter deficiency show moderate cognitive deficits
Hautman, E. R., Kokenge, A. N., Udobi, K. C., Williams, M. T., Vorhees, C. V., & Skelton, M. R. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9619-x · Cited by 29
Kan, H. E., Meeuwissen, E., van Asten, J. J., Veltien, A., Isbrandt, D., & Heerschap, A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01327.2006 · Cited by 28
Inhibition of Na+, K+‐ATPase activity in rat striatum by guanidinoacetate
Zugno, A. I., Stefanello, F. M., STRECK, E. L., Calcagnotto, T., Wannmacher, C. M. D., Wajner, M., & Wyse, Â. T. D. S. (2003) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(03)00038-8 · Cited by 26
Zugno, A. I., Franzon, R. C., Chiarani, F., Bavaresco, C. S., Wannmacher, C. M. D., Wajner, M., & Wyse, Â. T. D. S. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.05.002 · Cited by 26
Wang, L., Zhang, Y., Shao, M., & Zhang, H. (2007) · The International Journal of Developmental Biology · doi:10.1387/ijdb.062218lw · Cited by 25
Creatinyl amino acids—new hybrid compounds with neuroprotective activity
Burov, S., Leko, M., Dorosh, M., Dobrodumov, A., & Veselkina, O. (2011) · Journal of Peptide Science · doi:10.1002/psc.1379 · Cited by 24
Walker, J. B., & Hannan, J. K. (1976) · Biochemistry · doi:10.1021/bi00657a004 · Cited by 24
Biosynthesis of Guanidinoacetic Acid in Isolated Renal Tubules
Takeda, M., Kiyatake, I., Koide, H., Jung, K. Y., & Endou, H. (1992) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1992.30.6.325 · Cited by 24
Adriano, E., Garbati, P., Damonte, G., Salis, A., Armirotti, A., & Balestrino, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.018 · Cited by 23
Materno-Fetal Transport of Creatine in the Rat
Davis, B. M., Miller, R. K., Brent, R. L., & Koszalka, T. R. (1978) · Neonatology · doi:10.1159/000241050 · Cited by 23
Zugno, A. I., Pereira, L. O., Mattos, C., Scherer, E. B. S., Netto, C. A., & Wyse, Â. T. D. S. (2008) · Metabolic Brain Disease · doi:10.1007/s11011-008-9085-6 · Cited by 22
Guanidinoacetate Inhibits Glutamate Uptake in Rat Striatum of Rats at Different Ages
Zugno, A. I., de Oliveira, D. L., Scherer, E. B. S., et al. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9245-1 · Cited by 19
Guanidino compound levels in the serum of healthy adults and epileptic patients
Shiraga, H., Watanabe, Y., & Mori, A. (1991) · Epilepsy Research · doi:10.1016/0920-1211(91)90082-q · Cited by 17
GAMT deficiency: 20years of a treatable inborn error of metabolism
Braissant, O. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.11.002 · Cited by 16
Self-citationStöckler, S., Braissant, O., & Schulze, A. (2014) · Springer eBooks · doi:10.1007/978-3-642-40337-8_32 · Cited by 15
Self-citation[Amides of creatine: perspectives of neuroprotection].
Vlasov, T. D., Sg, C., Ae, B., et al. (2011) · PubMed · Cited by 3
Research works printed but not linked: 3
- Craigen WJ, Stromberger C, Donti T, Raghavan A, Ather S, Wehrens X, Akman HO (2011) A mouse model of creatine deficiency due to targeted disruption of Alanine: glycine Amidinotransferase exhibits muscle hypoplasia, mitochondrial dysfunction, and weakness. J Inherit Metab Dis 34:125
- Sinha A, Ahmed S, von Both I, Isbrandt D, Henkelman R, Schulze A (2011) Anatomical phenotyping in mouse models of AGAT and GAMT deficiency with magnetic resonance imaging. J Inherit Metab Dis 34:124
- Wilcken B, Fagan E, Sim K, Carpenter KH, Salomons GS (2008) Creatine transporter defect: results of 6 months’ treatment. J Inherit MetabDis 31(Suppl):70
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
“However, higher levels of creatine supplementation for longer periods of time may be needed to increase brain concentrations of creatine, offset creatine synthesis deficiencies, or influence disease states [13, 19, 23].”
BackgroundOxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell · doi:10.1111/acel.13031 · Cited by 778
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Metabolic Basis of Creatine in Health and Disease: A Bioinformatics-Assisted Review
Bonilla, D. A., Kreider, R. B., Stout, J. R., Forero, D. A., Kerksick, C. M., Roberts, M. D., & Rawson, E. S. (2021) · Nutrients · doi:10.3390/nu13041238 · Cited by 223
“Cr is one of the main osmolytes of the central nervous system, which may play important roles in pathophysiological conditions of the brain [18,19].”
BackgroundSchlattner, U., Klaus, A., Ramirez Rios, S., Guzun, R., Kay, L., & Tokarska-Schlattner, M. (2016) · Amino Acids · doi:10.1007/s00726-016-2267-3 · Cited by 96
Metadata
- Authors
- Hanna-El-Daher, L., & Braissant, O.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Braissant, Olivier
- ORCID
- Braissant, Olivier
- Venue
- Amino Acids
- Published
- 2016-02-10
- Volume
- 48
- Issue
- 8
- Pages
- 1877-1895
- ISSN
- 0939-4451 (ISSN-L)
- 1438-2199
- OpenAlex
- W2264834965
- Cited by
- 65
- References
- 129
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 3 · 2023: 4 · 2022: 8 · 2021: 13 · 2020: 1 · 2019: 8 · 2018: 4 · 2017: 6 · 2016: 6
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Amino Acids (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A-130278, 3100A0-116859)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- creatine synthesis, creatine deficiency syndrome, GAMT deficiency, SLC6A8, creatine transporter, blood-brain barrier, blood-CSF barrier, guanidinoacetic acid, astrocytes
- MeSH terms
- Amidinotransferases, Amino Acid Metabolism, Inborn Errors, Animals, Blood-Brain Barrier, Capillaries, Developmental Disabilities, Creatine, Disease Models, Animal, Humans, Language Development Disorders, Intellectual Disability, Movement Disorders, Nerve Tissue Proteins, Speech Disorders, Brain Diseases, Metabolic, Inborn, X-Linked Intellectual Disability, Endothelial Cells, Plasma Membrane Neurotransmitter Transport Proteins, Guanidinoacetate N-Methyltransferase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.